Patients can turn off an experimental treatment if side effects get too bad.
Susan YoungFollow @twitterapi
I’m the biomedicine editor for MIT Technology Review. I look for stories where technology stands to improve human health or advance our understanding of the human condition.
I joined MIT Technology Review in March 2012 after a brief stint in the Washington, D.C., news bureau of the scientific journal Nature. Before I ventured to the East Coast, I spent several years in the San Francisco Bay Area as a doctoral student in molecular biology and one whirlwind year in science-writing boot camp in Santa Cruz.
In California, I wrote for the Stanford University press offices, the Multiple Sclerosis Discovery Forum, and the Salinas Californian newspaper. I grew up in a small town in eastern Texas, surrounded by bird song, rolling cattle fields, and lanky pine trees. When I’m not exploring health tech, you will probably find me cooking or giggling over an exceptional LOLcat.
Susan Young's Stories
A light-sensitive polymer could offer a new way to develop artificial retinas.
Broadband communication and custom signal-processing chips power a new brain-recording device that may one day help paralyzed people.
Researchers explain the goals and structure of a new brain-mapping project.
Brain wave patterns show a clear transition to a coma-like state in patients under general anesthesia.
Researchers show that animals can collaborate via a brain-to-brain interface.
Pacemaker-like treatment calms an overactive circuit in the brains of OCD patients.
Nabsys’s technology could provide the positional accuracy missing from current DNA sequencing methods.
A device that uses no externally visible gear enables patients to read letters and see faces.
A new company offers a “gene vault” for doctors who want to add genomics to patient care.